Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
BioStem Technologies, Inc. (BSEM) had Consolidated Net Income/Loss of $31.88M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$31.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$31.88M |
|
|
Consolidated Net Income/Loss |
$31.88M |
-- |
|
-- |
|
-- |
|
16.35M |
|
21.69M |
|
$1.95 |
|
$1.47 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|